Quick Scoop

Preeclampsia testing involves a combination of regular blood pressure monitoring, urine tests, blood work, and sometimes specialized biomarker screening to identify this potentially serious pregnancy complication that typically develops after 20 weeks of gestation. Healthcare providers use multiple diagnostic approaches—from routine prenatal checks to advanced laboratory tests—to catch preeclampsia early and manage it effectively.

The Basics: Blood Pressure and Urine Checks

The foundation of preeclampsia testing starts with what happens at every prenatal visit. Your healthcare provider checks your blood pressure at each appointment, watching for readings of 140/90 mmHg or higher, which can signal trouble especially after the 20th week of pregnancy. Alongside blood pressure monitoring, a simple urine dipstick test screens for excess protein (called proteinuria), though it's worth noting that protein in urine is no longer an absolute requirement for diagnosis—it's just one piece of the puzzle that may indicate something's off.

Blood Tests: Getting to Know Your Numbers

When preeclampsia is suspected, your doctor orders a battery of blood tests to assess how well your organs are functioning. These tests examine:

  • Liver enzyme levels to check liver function
  • Platelet counts to see how well your blood is clotting
  • Serum creatinine to evaluate kidney health
  • Red blood cell counts to assess overall blood health

For patients newly diagnosed with gestational hypertension or showing symptoms of preeclampsia, the recommended panel includes serum creatinine, urinary albumin-creatinine ratio (or protein-creatinine ratio, or 24-hour urine total protein), liver enzymes, and platelet count.

Advanced Biomarker Testing

Modern preeclampsia screening has evolved to include specialized biomarker tests that can predict risk with impressive accuracy. First-trimester screening combines maternal risk factors with biochemical markers like PlGF (placental growth factor) and PAPP-A, plus biophysical markers including mean arterial pressure (MAP) and uterine artery pulsatility index, achieving sensitivity rates up to 90%. For women in their second or third trimester, the sFlt-1:PlGF ratio test helps assess whether preeclampsia might progress to severe features within the next two weeks, with sensitivity reaching 93.5%.

Additional Monitoring Methods

Beyond the standard tests, healthcare providers may perform:

  • Maternal weight checks to monitor for sudden, excessive weight gain
  • Ultrasounds to assess the baby's size and growth, since preeclampsia can affect fetal development
  • Urine microscopy for more detailed kidney assessment

Who Gets Baseline Testing?

For pregnant individuals with chronic hypertension, baseline testing at the start of pregnancy establishes initial kidney, liver, and blood values for future comparison if preeclampsia symptoms emerge later. This proactive approach helps doctors spot changes more quickly when they do occur.

TLDR

Preeclampsia testing combines routine blood pressure checks and urine tests at every prenatal visit with comprehensive blood work examining liver, kidney, and clotting function when symptoms arise. Advanced biomarker screening using PlGF, sFlt-1, and other indicators can predict preeclampsia risk with up to 90% accuracy in early pregnancy. The multi-layered testing approach helps catch this serious condition early, allowing for timely intervention to protect both mother and baby.

Information gathered from public forums or data available on the internet and portrayed here.